Evidence map›Paper›PMID 34961760›Full record

ArticleCell discovery2021

Histone lysine methacrylation is a dynamic post-translational modification regulated by HAT1 and SIRT2.

Kyle Delaney, Minjia Tan, Zhesi Zhu, Jinjun Gao, Lunzhi Dai, Sunjoo Kim, Jun Ding, Maomao He, Levon Halabelian, Lu Yang and 6 more

Open access · goldAbstract read
In one paragraph

Article in Cell discovery, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 34 papers.

0numbers the graph read from it
0cells of the map it votes in
34citing papers in PubMed
4.1field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

34 citing papers in PubMed, 55 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Biochemistry and regulation of histone lysine L-lactylation.Nature reviews. Molecular cell biology · 2026
    Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Discovery and Profiling of Protein CysteineMolecules (Basel, Switzerland) · 2025
    Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Review
  15. Article
  16. Review
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 8 institutions in 5 countries.

Kyle DelaneyBen May Department for Cancer Research, The University of Chicago, Chicago, IL, USA.
Minjia TanBen May Department for Cancer Research, The University of Chicago, Chicago, IL, USA.ORCID http://orcid.org/0000-0002-6784-9653
Zhesi ZhuDepartment of Pharmaceutical and Biomedical Sciences, University of Georgia, Athens, GA, USA.
Jinjun GaoBen May Department for Cancer Research, The University of Chicago, Chicago, IL, USA.ORCID http://orcid.org/0000-0002-7390-5578
Lunzhi DaiBen May Department for Cancer Research, The University of Chicago, Chicago, IL, USA.ORCID http://orcid.org/0000-0002-3003-8910
Sunjoo KimCollege of Pharmacy, Research Institute of Pharmaceutical Sciences, Kyungpook National University, Daegu, South Korea.
Jun DingBen May Department for Cancer Research, The University of Chicago, Chicago, IL, USA.
Maomao HeDepartment of Pharmaceutical and Biomedical Sciences, University of Georgia, Athens, GA, USA.
Levon HalabelianStructural Genomics Consortium, University of Toronto, Toronto, ON, Canada.ORCID http://orcid.org/0000-0003-4361-3619
Lu YangBen May Department for Cancer Research, The University of Chicago, Chicago, IL, USA.
Prabakaran NagarajanDepartment of Biological Chemistry and Pharmacology, The Ohio State University, Columbus, OH, USA.
Mark Robert ParthunDepartment of Biological Chemistry and Pharmacology, The Ohio State University, Columbus, OH, USA.
Sangkyu LeeCollege of Pharmacy, Research Institute of Pharmaceutical Sciences, Kyungpook National University, Daegu, South Korea.
Saadi KhochbinCNRS UMR 5309, INSERM, U1209, Université Grenoble Alpes, Institute for Advanced Biosciences, Grenoble, France.
Yujun George ZhengDepartment of Pharmaceutical and Biomedical Sciences, University of Georgia, Athens, GA, USA.
Yingming ZhaoBen May Department for Cancer Research, The University of Chicago, Chicago, IL, USA. yingming.zhao@uchicago.edu.
University of Chicago · USUniversity of Georgia · USKyungpook National University · KRThe Ohio State University · USCentre National de la Recherche Scientifique · FRChinese Academy of Sciences · CNSichuan University · CNUniversity of Toronto · CA

Funding

Multi-Disciplinary Training Grant in Cancer ResearchT32CA009594 · NCI · UNIVERSITY OF CHICAGO · PI KAY F MACLEOD, Scott A. Oakes · 1989 to 2026
$11.5M
Type B Histone Acetyltransferases and the Assembly of Chromatin StructureR01GM062970 · NIGMS · OHIO STATE UNIVERSITY · PI PARTHUN, MARK R · 2001 to 2018
$5.1M
Histone lactylation pathway in hair cycle: deacylases and their protein targetsR01AR078555 · NIAMS · UNIVERSITY OF CHICAGO · PI LIN, HENING, ZHAO, YINGMING · 2021 to 2025
$3.3M
Biochemistry of the lysine beta-hydroxybutyrylation pathwayR01DK118266 · NIDDK · UNIVERSITY OF CHICAGO · PI COLE, PHILIP A, ZHAO, YINGMING · 2018 to 2021
$2.1M
Systematic screening for new histone marks and studying their epigenetic functionR01GM135504 · NIGMS · UNIVERSITY OF CHICAGO · PI ZHAO, YINGMING · 2020 to 2023
$2.1M
Systems-wide analysis of histone lysine 2-hydroxyisobutyrylation pathwayR01GM115961 · NIGMS · UNIVERSITY OF CHICAGO · PI ZHAO, YINGMING · 2016 to 2019
$1.8M
NCI NIH HHS T32 CA009594NIAMS NIH HHS R01 AR078555NIDDK NIH HHS R01 DK118266NIGMS NIH HHS R01 GM062970NIGMS NIH HHS R01 GM135504U.S. Department of Health & Human Services | National Institutes of Health (NIH) R01DK118266U.S. Department of Health & Human Services | National Institutes of Health (NIH) R01GM062970U.S. Department of Health & Human Services | National Institutes of Health (NIH) R01GM115961Wellcome Trust
6 · The paper itself

Abstract

Histone lysine crotonylation is a posttranslational modification with demonstrated functions in transcriptional regulation. Here we report the discovery of a new type of histone posttranslational modification, lysine methacrylation (Kmea), corresponding to a structural isomer of crotonyllysine. We validate the identity of this modification using diverse chemical approaches and further confirm the occurrence of this type of histone mark by pan specific and site-specific anti-methacryllysine antibodies. In total, we identify 27 Kmea modified histone sites in HeLa cells using affinity enrichment with a pan Kmea antibody and mass spectrometry. Subsequent biochemical studies show that histone Kmea is a dynamic mark, which is controlled by HAT1 as a methacryltransferase and SIRT2 as a de-methacrylase. Altogether, these investigations uncover a new type of enzyme-catalyzed histone modification and suggest that methacrylyl-CoA generating metabolism is part of a growing number of epigenome-associated metabolic pathways.

Identifiers

PMID34961760
PMCPMC8712513
OpenAlexW4200147207

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.